Classical and alternative activation of mononuclear phagocytes: Picking the best of both worlds for tumor promotion

被引:279
作者
Van Ginderachter, Jo A. [1 ]
Movahedi, Kiavash [1 ]
Ghassabeh, Gholamreza Hassanzadeh [1 ]
Meerschaut, Sofie [1 ]
Beschin, Alain [1 ]
Raes, Geert [1 ]
De Baetselier, Patrick [1 ]
机构
[1] Vrije Univ Brussel VIB, Cellular & Mol Immunol Lab, Dept Mol & Cellular Interact, B-1050 Brussels, Belgium
关键词
alternative activation; classical activation; macrophages; cancer progression; myeloid suppressor cells; tumor-associated macrophages;
D O I
10.1016/j.imbio.2006.06.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mononuclear phagocytes often function as control switches of the immune system, securing the balance between pro- and anti-inflammatory reactions. For this purpose and depending on the activating stimuli, these cells can develop into different subsets: classically (M1) or alternatively (M2) activated mononuclear phagocytes, the molecular and functional characterization of which is a current topic of investigation. Accumulating evidence suggests that cells of the monocyte/macrophage lineage can be hijacked by tumors for their own benefit. Either as immature cells in the periphery, or as mature macrophages at the tumor site, mononuclear phagocytes are able to influence the behavior of cancer cells, shape the tumor microenvironment and subvert anti-tumor immunity, thereby contributing to tumor growth and progression. This review focuses on the mechanisms behind monocyte/macrophage-mediated tumor promotion and interprets the available data within the M1/M2 conceptual frame. (c) 2006 Elsevier GmbH. All rights reserved.
引用
收藏
页码:487 / 501
页数:15
相关论文
共 136 条
[1]   Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice [J].
Aharinejad, S ;
Paulus, P ;
Sioud, M ;
Hofmann, M ;
Zins, K ;
Schäfer, R ;
Stanley, ER ;
Abraham, D .
CANCER RESEARCH, 2004, 64 (15) :5378-5384
[2]  
ALBINA JE, 1990, J IMMUNOL, V144, P3877
[3]   Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer [J].
Almand, B ;
Clark, JI ;
Nikitina, E ;
van Beynen, J ;
English, NR ;
Knight, SC ;
Carbone, DP ;
Gabrilovich, DI .
JOURNAL OF IMMUNOLOGY, 2001, 166 (01) :678-689
[4]   Modulating macrophage function with IgG immune complexes [J].
Anderson, CF ;
Gerber, JS ;
Mosser, DM .
JOURNAL OF ENDOTOXIN RESEARCH, 2002, 8 (06) :477-481
[5]  
Baj-Krzyworzeka Monika, 2004, Cancer Immun, V4, P8
[6]   The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies [J].
Bingle, L ;
Brown, NJ ;
Lewis, CE .
JOURNAL OF PATHOLOGY, 2002, 196 (03) :254-265
[7]   A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-κB and enhanced IRF-3/STAT1 activation) [J].
Biswas, SK ;
Gangi, L ;
Paul, S ;
Schioppa, T ;
Saccani, A ;
Sironi, M ;
Bottazzi, B ;
Doni, A ;
Vincenzo, B ;
Pasqualini, F ;
Vago, L ;
Nebuloni, M ;
Mantovani, A ;
Sica, A .
BLOOD, 2006, 107 (05) :2112-2122
[8]   Identification of tumor-infiltrating macrophages as the killers of tumor cells after immunization in a rat model system [J].
Bonnotte, B ;
Larmonier, N ;
Favre, N ;
Fromentin, A ;
Moutet, M ;
Martin, M ;
Gurbuxani, S ;
Solary, E ;
Chauffert, B ;
Martin, F .
JOURNAL OF IMMUNOLOGY, 2001, 167 (09) :5077-5083
[9]   Tumor antigens recognized by T cells [J].
Boon, T ;
Coulie, PG ;
VandenEynde, B .
IMMUNOLOGY TODAY, 1997, 18 (06) :267-268
[10]   Stimulation of toll-like receptor 4 expression in human mononuclear phagocytes by interferon-γ:: a molecular basis for priming and synergism with bacterial lipopolysaccharide [J].
Bosisio, D ;
Polentarutti, N ;
Sironi, M ;
Bernasconi, S ;
Miyake, K ;
Webb, GR ;
Martin, MU ;
Mantovani, A ;
Muzio, M .
BLOOD, 2002, 99 (09) :3427-3431